Selected article for: "central nervous system and high morbidity"

Author: Unver, Edhem; Kuyrukluyildiz, Ufuk; Karavas, Erdal; Tas, Hakan Gokalp
Title: Case report: cerebral thromboembolism in an unconscious COVID-19 patient in intensive care
  • Cord-id: r1n3h72k
  • Document date: 2021_4_15
  • ID: r1n3h72k
    Snippet: Although the severity of coronavirus disease 2019 (COVID-19) being more frequently related to acute respiratory distress syndrome and acute cardiac and renal injuries, thromboembolic events have been increasingly reported. Acute respiratory distress syndrome due to SARS-CoV-2 (Severe Acute Respiratory Syndrome - Corona Virus 2) often requires intensive care follow-up. As well as respiratory failure, the SARS-CoV-2 may cause central nervous system (CNS) involvement. The pandemic has raised many c
    Document: Although the severity of coronavirus disease 2019 (COVID-19) being more frequently related to acute respiratory distress syndrome and acute cardiac and renal injuries, thromboembolic events have been increasingly reported. Acute respiratory distress syndrome due to SARS-CoV-2 (Severe Acute Respiratory Syndrome - Corona Virus 2) often requires intensive care follow-up. As well as respiratory failure, the SARS-CoV-2 may cause central nervous system (CNS) involvement. The pandemic has raised many challenges in managing critically ill older adults, a population preferentially killed by COVID-19. The mortality and morbidity rates are extremely high in critically ill patients with COVID-19. Recent studies have reported the potential development of a hypercoagulable state in COVID-19. Viral infections and hypoxia may cause these state. It is increasingly reported that thromboembolic events are associated with a poor prognosis. Due to these thromboembolic complications, COVID-19 patients often have neurological symptoms. These symptoms may not be observed in intensive care patients who are sedated. We report one case who was sedated COVID-19 pneumonia and who was later diagnosed with cerebral venous thrombosis with cranial imaging when he could not awaken even though sedation was discontinued. Since COVID-19 causes intense thrombotic susceptibility due to cytokine storm, cerebrovascular thromboembolic complications associated with COVID-19 infection should be considered first and foremost for unconsciousness ventilated patients. Severe and potentially cerebral thrombosis may prolong the patient´s stay in intensive care.

    Search related documents:
    Co phrase search for related documents
    • acute ards respiratory distress syndrome and low molecular weight heparin: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • acute ards respiratory distress syndrome and low tidal volume: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute ards respiratory distress syndrome and lung auscultation: 1, 2, 3
    • acute ards respiratory distress syndrome and lung basis: 1, 2
    • acute ards respiratory distress syndrome and lung protective ventilation treatment: 1, 2, 3, 4, 5, 6
    • acute ards respiratory distress syndrome and lymphocyte count: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute ards respiratory distress syndrome and lymphocyte low: 1, 2
    • acute ards respiratory distress syndrome diagnosis and low tidal volume: 1
    • acute brain disease and low molecular weight heparin: 1
    • acute cardiac and low molecular weight heparin: 1, 2
    • acute cardiac and lung basis: 1
    • acute cardiac and lymphocyte count: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
    • acute cardiac and lymphocyte low: 1, 2
    • low molecular weight heparin and lung protective ventilation treatment: 1
    • low molecular weight heparin and lymphocyte count: 1, 2, 3, 4
    • lung auscultation and lymphocyte count: 1
    • lung basis and lymphocyte count: 1